Retraction
A Novel Necroptosis-Related lncRNA Signature for Osteosarcoma
Paper Information
Record ID:
60324
Author(s):
Publication Date:
July 07, 2022
Retraction Date:
November 29, 2023
(2.0 year years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9812519Additional Notes:
See also: https://pubpeer.com/publications/ACC788DD1EA38B8DFB85B63DE066DA
Citations (11)
11
Total Citations6
Post-Retraction(54.5%)
5
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
5
Within 1 year
0
After 2+ years
458
Days since retraction (latest)
Long noncoding RNA BCAR4 regulates osteosarcoma progression by targeting microRNA-1260a
Yixin Pan, Tang Xiaolei, Yadong Xie et al. (6 authors)
Bulletin du Cancer
Open Access
Published: Mar 2025
458 days after retraction
The fate and function of non-coding RNAs during necroptosis
Esra Bozgeyi̇k, Alperen Elek, Zekihan Gocer et al. (4 authors)
Epigenomics
Published: Jun 2024
1 citation
1 citation
201 days after retraction
The role of programmed cell death in osteosarcoma: From pathogenesis to therapy
Suqing Liu, Chengtao Liu, Yian Wang et al. (10 authors)
Cancer Medicine
Open Access
Published: May 2024
4 citations
4 citations
154 days after retraction
A novel PANoptosis-related lncRNA model for forecasting prognosis and therapeutic response in hepatocellular carcinoma
Chenlu Lan, Haifei Qin, Zaida Huang et al. (12 authors)
Research Square (Research Square)
Open Access
Published: Jan 2024
51 days after retraction
Identification of TNFRSF1A as a potential biomarker for osteosarcoma
Yuke Zhang, Kai Liu, Jianzhong Wang
Cancer Biomarkers
Open Access
Published: Jan 2024
1 citation
1 citation
48 days after retraction
Comparative proteomics reveal the humoral immune rejection of pearl oyster Pinctada fucata to xenograft from Pinctada maxima
Pei Wang, Ying Guo, Suping Li et al. (8 authors)
Aquaculture
Published: Dec 2023
5 citations
5 citations
28 days after retraction
The role of pyroptosis-related lncRNA risk signature in ovarian cancer prognosis and immune system
Yan‐Ling Wu, Lei Liang, Qin Li et al. (6 authors)
Discover Oncology
Open Access
Published: Aug 2023
2 citations
2 citations
102 days before retraction
Necroptosis in the sarcoma immune microenvironment: From biology to therapy
Huali Ye, Minxun Lu, Chongqi Tu et al. (4 authors)
International Immunopharmacology
Published: Jul 2023
2 citations
2 citations
135 days before retraction
Retracted: A Novel Necroptosis‐Related lncRNA Signature for Osteosarcoma
Computational and Mathematical Methods in Medicine
Computational and Mathematical Methods in Medicine
Open Access
Published: Jan 2023
332 days before retraction
A risk model based on ferroptosis- and cuproptosis-related lncRNAs predicts prognosis and immune microenvironment in lung adenocarcinoma by bioinformatics analysis and experimental verification.
Xiao‐Ying Xu, Xinzhi Feng, Pengju Zhang et al. (4 authors)
PubMed
Published: Jan 2023
332 days before retraction
Identification and Validation of Lipid Metabolism-Related LncRNA Prognostic Signature for Patients with Osteosarcoma
Zhifang Tang, Hanzhen Feng, Longjun Shu et al. (9 authors)
Research Square (Research Square)
Open Access
Published: Dec 2022
348 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
2.0 year
Open Access:
Yes
Last Checked:
Jul 24, 2025